Kyntra Bio KYNB
NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Kyntra Bio (KYNB) Gains from Investment Securities (2015 - 2023)

Updated

Analysis

Kyntra Bio (KYNB) Gains from Investment Securities (2015 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Kyntra Bio 12.57 Mn -395.37 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -271,000.00
Mar 31, 2022 -5,000.00
Dec 31, 2021 -18,000.00
Sep 30, 2021 -4,000.00
Jun 30, 2021 -8,000.00
Mar 31, 2020 -258,000.00
Dec 31, 2019 10,000.00
Sep 30, 2019 19,000.00
Jun 30, 2019 8,000.00
Mar 31, 2019 51,000.00
Dec 31, 2018 -1.21 Mn
Jun 30, 2018 -78,000.00
Mar 31, 2018 165,000.00
Sep 30, 2017 48,000.00
Jun 30, 2017 65,000.00
Mar 31, 2017 30,000.00
Dec 31, 2016 -399,000.00
Sep 30, 2016 163,000.00
Jun 30, 2016 -347,000.00
Mar 31, 2016 620,000.00
API Access

Kyntra Bio Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=KYNB&period=max&api_key=YOUR_API_KEY